Skip to main content
. 2015 Oct 26;27(1):62–68. doi: 10.1093/annonc/mdv488

Figure 1.

Figure 1.

Grade 3/4 neutropenia (A) and thrombocytopenia (B) associated with lenalidomide (LEN) treatment by cycle in MDS-004 [32, 33].